VIRAL BIOSAFETY OF BIOPHARMACEUTICALS

VIRAL BIOSAFETY OF BIOPHARMACEUTICALS

Therapeutics produced by eukaryotic cell lines could possible be contaminated with bioburden; the most dangerous for human is viral contamination. The article describes the problem of viral safety of biopharmaceuticals. The strategy of downstream process steps for the viral safety guarantee is discu...

Full description

Saved in:

Bibliographic Details
Main Author:	D. A. Gusarov
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-01-01
Series:	Разработка и регистрация лекарственных средств
Subjects:	viruses biosafety inactivation nanofiltration chromatography
Online Access:	https://www.pharmjournal.ru/jour/article/view/226
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Establishing a national biosafety and biosecurity agency for the United States
by: David R. Gillum, et al.
Published: (2024-10-01)

Biosafety perspective of clinical laboratory workers: a profile of Pakistan
by: Sadia Nasim, et al.
Published: (2012-08-01)

Biosafety and Environmental Risks of Genetically Modified Plants.
by: Anmar Alalwani, et al.
Published: (2024-06-01)

Cleaning methods for biosafety cabinet to eliminate residual mycoplasmas, viruses, and endotoxins after changeover
by: Mitsuru Mizuno, et al.
Published: (2025-03-01)

Biosafety and pharmacokinetic characteristics of polyethylene pyrrolidone modified nano selenium in rats
by: Wei Li, et al.
Published: (2024-11-01)

Validated Methods for Inactivation of Tick-Borne Encephalitis Virus Compatible with Immune-Based and Enzymatic Downstream Analyses
by: Simone Leoni, et al.
Published: (2025-06-01)

BIOSAFETY PROVISIONS IN BACTERIOLOGICAL LABORATORIES OF THE RUSSIAN TB UNITS
by: E. V. Sevаstyanovа, et al.
Published: (2017-05-01)

Assessing the evidence for effective biosafety risk management in Coxiella burnetii research
by: S.D. Blacksell, et al.
Published: (2025-12-01)

Construction and validation of an educational game on biosafety in the central sterile supply department
by: Tatiana Nemoto Piccoli Moraes, et al.
Published: (2024-12-01)

Laboratory biosafety issues related to coronavirus disease 2019
by: Vivek Bhat, et al.
Published: (2020-01-01)

Assessment of biosafety measures in clinical laboratories of Al-Madinah city, Saudi Arabia
by: Omar Falah Khabour, et al.
Published: (2018-09-01)

Biosafety Aspects of Hybridoma Technology: Nature of Risks and Approaches to Their Management
by: Kateryna Shevchuk, et al.
Published: (2025-04-01)

Exploring potential biosafety implications in DNA information storage
by: Shangzhe Li, et al.
Published: (2025-04-01)

Biosafety and Genomic Epidemiological Surveillance
by: V. G. Akimkin, et al.
Published: (2024-11-01)

Challenges in the establishment of a biosafety testing laboratory for COVID-19 in Bangladesh
by: SM Rashed Ul Islam, et al.
Published: (2021-12-01)

Domestication of the African regional biosafety and biosecurity legislative framework – Lessons learned from the first four countries: Zambia, Botswana, Lesotho, and Sierra Leone
by: Christine Fortunate Rebecca Mutesi, et al.
Published: (2025-12-01)

A targeted vaccination strategy: Integrating vaccines into biosafety, biosecurity, and one health initiatives
by: Laith N. AL-Eitan, et al.
Published: (2025-03-01)

Biosafety and biosecurity problems in Ukraine that arise during emergent infections
by: A. O. Vysotskyi, et al.
Published: (2025-03-01)

Biosafety status analysis and risk assessment of laboratories from 2021 to 2023 in Jiaxing, China
by: Yong Yan, et al.
Published: (2025-04-01)

Harnessing Hazara Virus as a Surrogate for Crimean–Congo Hemorrhagic Fever Virus Enables Inactivation Studies at a Low Biosafety Level
by: Judith Olejnik, et al.
Published: (2025-07-01)

Antimicrobial Resistance: A Risk Factor for the Biosafety System
by: S. N. Orekhov, et al.
Published: (2023-09-01)

Chemotherapeutic dihydromyricetin with remarkable anti-tumor activity and biosafety for muscle invasive bladder cancer
by: Zicheng Guo, et al.
Published: (2025-07-01)

Editorial: Xenobiotics and emerging contaminants in ecosystems: innovative geo-microbial strategies for prevention, efficient clean-up and biosafety
by: Balaram Mohapatra, et al.
Published: (2025-05-01)

Biosafety Evaluation of a Chimeric Adenoviral Vector in Mini-Pigs: Insights into Immune Tolerance and Gene Therapy Potential
by: Andrei Izmailov, et al.
Published: (2024-11-01)

Betulinic Acid-Loaded Oleogel as a Novel Pharmaceutical Formulation for Potential Cutaneous Applications: Development, Characterization, and Biosafety Profile
by: Andreea Smeu, et al.
Published: (2025-06-01)

Assessment of biosafety training and practices in biomedical laboratories in Kinshasa, Democratic Republic of the Congo
by: Diane Sare Gamani, et al.
Published: (2025-07-01)

Commentary on the African Biological Safety Association inaugural meeting: March 8 - 12 2010
by: Louise Bezuidenhout
Published: (2010-06-01)

Chemical and Heat Treatment for Viral Inactivation in Porcine-Derived Gelatin
by: Francois Marie Ngako Kadji, et al.
Published: (2024-12-01)

Association between occupational stress and work-related musculoskeletal disorders of staff in biosafety laboratories in Xinjiang
by: JU Keke
Published: (2024-08-01)

The Attribution of Human Seasonal Influenza H3N2 Virus Detection to the Collector, Not Avian Sources, During the 2022 Highly Pathogenic Avian Influenza Outbreak in Pennsylvania, USA—Implications for Biosafety and Biosecurity
by: Deepanker Tewari, et al.
Published: (2024-12-01)

Biosafety considerations triggered by genome-editing technologies
by: Xinxin Li, et al.
Published: (2025-06-01)

Biosafety characteristics and antibacterial activity of probiotic strains against Streptococcus mutans, Aggregatibacter actinomycetemcomitans, and Porphyromonas gingivalis
by: Jeong-Yong Park, et al.
Published: (2025-01-01)

Viral inactivation in von Willebrand factor preparations via UVC irradiation: an experimental approach
by: ZHANG Yalu, et al.
Published: (2025-05-01)

Inactivation of Aerosolized Hepatitis A Viral Droplets on Food Contact Surfaces by Ultraviolet-Light-Emitting Diodes at 255 nm and 279 nm
by: Breanna Polen, et al.
Published: (2025-05-01)

Modeling of Nanofiltration of Low Concentration Pb(II) Aqueous Solutions Using a Coupled Concentration Polarization and Pore Flow Model
by: S. Fadhil
Published: (2019-10-01)

Morphological and Functional Characteristics of the Microenvironment After Pleural Implantation of Biosynthetic Materials
by: G. A. Demyashkin, et al.
Published: (2023-03-01)

DOWNSTREAM PROCESS OF BIOPHARMACEUTICALS
by: D. A. Gusarov
Published: (2019-01-01)

Safety and immunogenicity of inactivated Zika virus vaccine by gamma irradiation
by: Pumin Sintara, et al.
Published: (2025-10-01)

Investigating the Effect of Different Wavelengths of UV Radiation in Disinfection of Airborne and Surface SARS-Cov-2
by: Ali Behnami, et al.
Published: (2025-06-01)

Assessing Virus Survival in African Swine Fever Virus-Contaminated Materials—Implications for Indirect Virus Transmission
by: Christina Marie Lazov, et al.
Published: (2025-01-01)